Clinical Trial Update: Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the combination of Edotecarin and Cisplatin in patients with advanced or metastatic solid tumors, including esophageal and gastric ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Edotecarin (edotecarin)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Esophageal Cancer, Gastric Cancer | Phase 1 | Status: COMPLETED